Navigation Links
New and unique treatment for Psoriasis patients

Psoriasis patients who have been long-awaiting new options in treatment, now have fresh hope with the Food and Drug Administration's approval of the new drug, Amevive. This unique drug targets renegade immune cells to control hard-to-treat psoriasis. Psoriasis has been thought to occur when the immune system goes amok and cells called memory effector T cells prompt skin inflammation. The treatments that are currently available for psoriasis range from ointments to ultraviolet therapy to other injected drugs that can broadly suppress// the immune system. The new drug Amevive, however has been designed to target only the harmful T cells, instead of the entire immune system. Physicians have been eagerly awaiting the drug as it works differently from those drugs that are available in the market presently.

The drug, whose effect has not yet been compared with existing treatments, will be marketed in intravenous and intra-muscular injection forms. The treatment, for a 12-week course, will cost between $7000 and $10,000 and the weekly dose will be administered under the supervision of a doctor.

Biogen Inc., the makers of the drug, sponsored a study, which involved patients with chronic psoriasis that covered at least 10 percent of their bodies, and gave them either Amevive or dummy injections. They found that 40 per cent of patients on the Amevive drug saw their psoriasis symptoms cut in half, as compared to about 10 percent of placebo-treated patients. A small number of patients even saw their lesions almost vanish, for at least a while. Though the duration for which the effect lasted was not known, a small subset of patients went seven months or longer before needing additional treatment. The FDA's Dr. Karen Weiss cautioned that though the drug has a much more selective effect, it is still too soon to say it is very selective and very safe. In fact, she added that patients on the drug would require a blood test before each weekly dose to ensure the
'"/>




Page: 1 2

Related medicine news :

1. A unique factor in breathing disorder
2. Pink Shawl Project is a unique initiative
3. Thyroid hormone treatment hastens recovery after cardiac surgery
4. Feeding channel created by malaria parasite - a new target for malaria treatments
5. Now umbilical cord helps in stroke treatment.
6. Now AIDS treatment comes dirt-cheap
7. Breast cancer treatment to be determined by gene test
8. Hemopurifier may revolutionise AIDS treatment
9. New drug helps boost cancer treatment
10. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
11. Experimental treatment for Ebola Virus Shows promising results in mice
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New and unique treatment for Psoriasis patients

(Date:11/27/2014)... 2014 “Wekho” was featured on NewsWatch as ... coolest mobile applications on the iOS, Android, and Windows markets. ... conducted the app review and shared with viewers ... , An interesting new way to travel and experience the ... It’s called Wekho and it’s a free geolocation app ...
(Date:11/27/2014)... This is a professional and in ... an overview analysis, the report introduces Insulin basic ... industry overview, policy analysis, and news analysis, etc. ... information on policy, plans for Insulin Market product ... more. , This report also provides ...
(Date:11/27/2014)... 2014 At The Little Gym, we ... came as no surprise when a recent study confirmed ... success. The Journal of Pediatrics found that ... tasks during the school years may be important not ... The study monitored two groups of children; those that ...
(Date:11/27/2014)... 2014 The Emerald Cup 2014 Competition ... At This Year’s Entries | SKUNK Magazine – Proudly ... Two At Their Resort, Pure Garden, In Negril, Jamaica ... Hempcon, The Emerald Cup is presented by locals, for ... of California’s original cannabis industry." – SFGate, Smell The ...
(Date:11/27/2014)... November 27, 2014 In addition to ... an important gift home this holiday season and become ... disease. Visiting with relatives over the holidays may raise ... members. Although some change in cognitive ability can occur ... of normal aging. Recognizing the difference between normal aging ...
Breaking Medicine News(10 mins):Health News:A New Geolocation Mobile Application and was Featured on NewsWatch Television on October 30, 2014 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 2Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 3Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 5
... Athens, Ga. - Pharmaceutical companies and universities are racing to ... RNA interference to treat a host of diseases. Now, a ... powerful tool: Researchers at the University of Georgia have demonstrated ... as a tool in the development of vaccines. , ...
... Dec. 10 /PRNewswire/ - Over 830 staff members are ... District,s newest fitness challenge. The 322 mile virtual race ... online challenge and it,s proving successful with less work ... Lee County School District has delivered fitness ...
... A University of British Columbia geneticist has discovered a gene ... uveal melanoma. , Catherine Van Raamsdonk, an assistant professor of ... team of researchers, have discovered a genetic mutation in a ... cent of the cases of uveal melanoma. , The findings, ...
... survey cites misperceptions regarding need for vaccination and a lack of ... , ... Bethesda, MD (PRWEB) December 10, 2008 -- A ... one-third (29.6 percent) have been vaccinated against the flu this season. ...
... superior to vitamin supplementation for cancer prevention. , ... ... of announcements two weeks ago that vitamin supplements A thru E ... more medical announcements with the same conclusions regarding prostate cancer. While ...
... 10 Markel Corporation is,pleased to announce the launch ... product. DataBreach(SM) helps businesses manage,risk associated with their reliance ... in their custody or care. , ... the increase in identity theft,that has been plaguing businesses ...
Cached Medicine News:Health News:Study first to show that RNA interference can facilitate vaccine development 2Health News:Study first to show that RNA interference can facilitate vaccine development 3Health News:Lee County School District online wellness program inspires employees to walk 200 million steps in 2 months 2Health News:UBC researchers discover gene mutation that causes eye cancer 2Health News:Mid-Season Flu Immunization Rates are Too Low 2Health News:Mid-Season Flu Immunization Rates are Too Low 3Health News:Mid-Season Flu Immunization Rates are Too Low 4Health News:Mid-Season Flu Immunization Rates are Too Low 5Health News:Treadmill Desks More Effective in Decreasing Prostate Cancer Risks Than Vitamin and Antioxidant Supplements 2Health News:Markel Corporation Announces New DataBreach(SM) Privacy Liability Coverage 2
(Date:11/26/2014)... Nov. 25, 2014  Medtronic,s roughly $43 ... been widely discussed in the media for its ... a stronger leading player in one of the ... The healthcare market research firm said  the two ... a diverse set of solutions spanning inpatient to ...
(Date:11/26/2014)... , Nov. 25, 2014  Array ... today announced that its Chief Executive Officer, ... the following upcoming conferences.  The public is ... webcasts on the Array BioPharma website:  ... 3, 2014Time:1:30 p.m.  Eastern Time Location: Palace ...
(Date:11/26/2014)... PITUACH, Israel, Nov. 25, 2014 Immune Pharmaceuticals ... clinical stage biopharmaceutical company that engages in the ... treatment of inflammatory diseases and cancer, today announced ... offering of 3,450,000 units, with each unit consisting ... par value $0.0001 per share, and one warrant ...
Breaking Medicine Technology:Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 4Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 5
... Exceptionally high costs.  Long research and development cycles.  Low ...  Dependence on out-dated information technology options.  It,s not just ... information being wasted.   Such ... have led to the formation of a new company, ...
... -- XIANYANG, China, Aug. 17 /PRNewswire-Asia-FirstCall/ -- ... ... var ... keyed by longUrl, so we need to grab the first one. for (var r in data.results) ...
Cached Medicine Technology:RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development 2RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development 3RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development 4Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 2Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 3Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 4Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 5Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 6Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 7Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 8Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 9Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 10Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 11Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 12Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 13Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 14Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 15
... For treatment of carpal tunnel syndrome, mild ... following cast removal. The perforated suede ... the wrist, wicking away moisture for long ... metal splint prevents painful wrist flexion, and ...
... orthotic elbow system that can be used in ... proximal ulnar fractures or post reconstructive surgery where ... highly flexible system that provides you with a ... that best fits your patients needs. Two ...
A lightweight soft good with rigid elbow protection. Designed by medical professionals with your needs in mind. Provides elbow stability for mild to moderate medial/lateral and hyperextension injurie...
Worn by many professional athletes, EpiTrain is our most popular elbow support....
Medicine Products: